Effects and treatment methods of acupuncture and herbal medicine for premenstrual syndrome/premenstrual dysphoric disorder: systematic review

BMC Complementary and Alternative Medicine

Min-Sun Choi²  Dong Il Kim²  Su Hee Jang¹ 

[1] Department of Acupuncture and Moxibustion, Nasaret Oriental Medical Hospital, Inchon, South Korea;Department of Korean Gynecology, College of Korean Medicine, Dongguk University, Seoul, South Korea

关键词: PMDD;    PMS;    CAM;    TCM;    Herbal medicine;    Acupuncture;    Premenstrual dysphoric disorder;    Premenstrual syndrome;   

Others  :  1220349
DOI  :  10.1186/1472-6882-14-11

 received in 2012-11-10, accepted in 2014-01-08,  发布年份 2014

【 摘 要 】

Background

During their reproductive years about 10% of women experience some kind of symptoms before menstruation (PMS) in a degree that affects their quality of life (QOL). Acupuncture and herbal medicine has been a recent favorable therapeutic approach. Thus we aimed to review the effects of acupuncture and herbal medicine in the past decade as a preceding research in order to further investigate the most effective Korean Medicine treatment for PMS/PMDD.

Methods

A systematic literature search was conducted using electronic databases on studies published between 2002 and 2012. Our review included randomized controlled clinical trials (RCTs) of acupuncture and herbal medicine for PMS/PMDD. Interventions include acupuncture or herbal medicine. Clinical information including statistical tests was extracted from the articles and summarized in tabular form or in the text. Study outcomes were presented as the rate of improvement (%) and/or end-of-treatment scores.

Results

The search yielded 19 studies. In screening the RCTs, 8 studies in acupuncture and 11 studies in herbal medicine that matched the criteria were identified. Different acupuncture techniques including traditional acupuncture, hand acupuncture and moxibustion, and traditional acupuncture technique with auricular points, have been selected for analysis. In herbal medicine, studies on Vitex Agnus castus, Hypericum perforatum, Xiao yao san, Elsholtzia splendens, Cirsium japonicum, and Gingko biloba L. were identified. Experimental groups with Acupuncture and herbal medicine treatment (all herbal medicine except Cirsium japonicum) had significantly improved results regarding PMS/PMDD.

Conclusions

Limited evidence supports the efficacy of alternative medicinal interventions such as acupuncture and herbal medicine in controlling premenstrual syndrome and premenstrual dysphoric disorder. Acupuncture and herbal medicine treatments for premenstrual syndrome and premenstrual dysphoric disorder showed a 50% or better reduction of symptoms compared to the initial state. In both acupuncture and herbal medical interventions, there have been no serious adverse events reported, proving the safety of the interventions while most of the interventions provided over 50% relief of symptoms associated with PMS/PMDD. Stricter diagnostic criteria may have excluded many participants from some studies. Also, depending on the severity of symptoms, the rate of improvement in the outcomes of the studies may have greatly differed.

【 授权许可】

   
2014 Jang et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Greene R, Dalton K: The premenstrual syndrome. Br Med J 1953, 9:1007-1014.
• [2]Pearlstein T, Steiner M: Premenstrual dysphoric disorder: burden of illness and treatment update. J Psychiatry Neurosci 2008, 33:291-301.
• [3]O’Brien PM: Helping women with premenstrual syndrome. Br Med J 1993, 307:1471-1475.
• [4]DeMonico SO, Brown CS, Ling FW: Premenstrual syndrome. Curr Opin Obstet Gynecol 1994, 6:499-502.
• [5]Choi DS: Premenstrual syndrome. J Women Med 2009, 2(4):141-146.
• [6]Kim SY, Park HJ, Lee H: Acupuncture for premenstrual syndrome: a systematic review and meta-analysis of randomized controlled trials. BJOG 2011, 118:899-915.
• [7]PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement criteria http://www.prisma-statement.org/statement.htm webcite
• [8]Chou PB, Morse CA, Xu H: A controlled trial of Chinese herbal medicine for premenstrual syndrome. J Psychosom Obstet Gynaecol 2008, 29(3):185-192.
• [9]Kim SC, Kim SN, Lim JA, Choi CM, Shim EK, Koo ST, Ha JY, Sing KR, Sohn IC: Effects of acupuncture treatment on the premenstrual syndrome: controlled clinical trial. J Korean A&M Soc 2005, 22(1):41-60.
• [10]Habek D, Habek JČ, Barbir A: Using acupuncture to treat premenstrual syndrome. Arch Gynecol Obstet 2002, 267:23-26.
• [11]Shin KR, Young HJ, Park HJ, Heitkemper M: The effect of hand acupuncture therapy and hand moxibustion therapy on premenstrual syndrome among Korean women. West J Nurs Res 2009, 31(2):171-186.
• [12]Xu Y: Clinical Study on the Treatment of Acupuncture of Back-Shu on Premenstrual Syndrome. Harbin: Heilongjiang University of Chinese Medicine; 2006:1-33.
• [13]Xu Y, Sun Y: Observation of therapeutic effect of point-through point acupuncture method in the back on premenstrual syndrome. J Clin Acupunct Moxibust 2006, 22:37-38.
• [14]Guo S, Sun Y: Comparison between acupuncture and medication in treatment of premenstrual syndrome. Shanghai J Acupunct Moxibust 2004, 23:5-6.
• [15]Hong Y: Clinical therapeutic effect of scalp acupuncture on premenstrual tension syndrome. Chin Acupunct Moxibust 2002, 22(9):597-598.
• [16]Yu J: Preliminary observation based on a systematic review of efficacy and safety of acupuncture treatment for premenstrual syndrome. Acupunct Dep 2006, 1-89.
• [17]Ma L: Evaluating therapeutic effect in symptoms of moderate to severe premenstrual syndrome with Vitex Agnus castus (BNO 1095) in Chinese women. Aust N Z J Obstet Gynecol 2010, 50:189-193.
• [18]He Z, Chen R, Zhou Y, Geng L, Zhang Z, Chen S, Yao Y, Lu J, Lin S: Treatment for premenstrual syndrome with Vitex Agnus castus: a prospective, randomized, multicenter placebo controlled study in China. Maturitas 2009, 63(1):99-103.
• [19]Atmaca M, Selahattin K, Ertan T: Fluoxetine versus Vitex Agnus castus extract in the treatment of premenstrual dysphoric disorder. Human Psychopharmacol 2003, 18:191-195.
• [20]Zamani M, Nosrat N, Saadat T: Therapeutic effect of Vitex Agnus castus in patients with premenstrual syndrome. Acta Med Iran 2012, 50(2):101-106.
• [21]Canning S, Waterman M, Orsi N, Ayres J, Simpson N, Dye L: The efficacy of Hypericum perforatum (St John’s wart) for the treatment of premenstrual syndrome: a randomized, double-blind, placebo-controlled trial. CNS Drugs 2010, 24(3):207-225.
• [22]Hicks SM, Walker AF, Gallagher J, Middleton RW, Wright J: The significance of “nonsignificance” in randomized controlled studies: a discussion inspired by a double-blinded study on St. John’s wart (Hypericum perforatum L.) for premenstrual symptoms. J Altern Complement Med 2004, 10(6):925-932.
• [23]Masumeh G, Masumeh K, Nasrin A, Fariborz G, Samaneh Z, Hamid RT, Maryam D: Hypericum perforatum for the treatment of premenstrual syndrome. Int Fed Gynecol Obstet 2010, 11:7.
• [24]Agha-Hosseini M, Kashani L, Aleyaseen A, Ghoreishi A, Rahmanpour H, Zarrinara AR, Akhondzadeh S: Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomized and placebo controlled trial. BJOG 2008, 115:515-519.
• [25]Chung MS, Kim GH: Effects of Elsholtzia splendens and Cirsium japonicum on premenstrual syndrome. Nutr Res Pract 2010, 4(4):290-294.
• [26]Ozgoli G, Selselei EA, Mojab F, Majd HA: A randomized, placebo controlled trial of Ginkgo biloba L. in treatment of premenstrual syndrome. J Altern Complement Med 2009, 15(8):845-851.
• [27]van Die MD, Burger HG, Teede HJ, Bone KM: Vitex agnus-castus extracts for female reproductive. Disorders: a systematic review of clinical trials. Planta Med 2013, 79:562-575.
• [28]Cho SH, Kim J: Efficacy of acupuncture in management of premenstrual syndrome: a systematic review. Complement Ther Med 2010, 18(2):104-111.
• [29]Dante G, Facchinetti F: Herbal treatments for alleviating premenstrual symptoms: a systematic review. J Psychosom Obstet Gynaecol 2011, 32(1):42-51.
• [30]Wood SH, Mortola JF, Chan YF, Moossazadeh F, Yen SSC: Treatment of premenstrual syndrome with fluoxetine: a double-blind, placebo-controlled, crossover study. Obstet Gynecol 1992, 80:339-344.
• [31]Diegoli MSC, Fonseca AM, Diegoli CA, Pinotti JA: A double-blind trial of four medications to treat severe premenstrual syndrome. Int J Gynecol Obstet 1998, 62:63-67.
• [32]Yang YQ, Huang GY: Study on effects of acupuncture on mice dysmenorrheal model and the mechanism. Zhongguo Zhen Jiu 2008, 28:119-121.
• [33]Zhou J, Qu F: Treating gynecological disorders with traditional chin medicine: a review. Afr J Tradit Complement Altern Med 2009, 6(4):500-501.
• [34]Singh BB, Berman BM, Simpson RL: Incidence of premenstrual syndrome and remedy usage: a national probability sample study. Altern Ther Health Med 1998, 4(3):75-79.
• [35]Hardy ML: Herbs of special interest to women. J Am Pharm Assoc 2000, 40(2):234-242.
• [36]Calapai G, Crupi A, Firenzuoli F, Inferrera G, Squadrito F, Parisi A, De Sarro G, Caputi A: Serotonin, norepinephrine and dopamine involvement in the antidepressant action of hypericum perforatum. Pharmacopsychiatry 2001, 34(2):45-49.
• [37]Duvan CI, Cumaoglu A, Turhan NO, Karasu C, Kafali H: Oxidant/antioxidant status in premenstrual syndrome. Arch Gynecol Obstet 2011, 283:299-304.
• [38]Youn JS: Comparison study on the beneficial effect of Elsholtzia splendens and Elsholtzia ciliate. J Herbol 1992, 7:33-45.
• [39]Zou Y, Lu Y, Wei D: Antioxidant activity of a Flavonoid-Rich Extract of Hypericum perforatum L. in Vitro. J Agric Food Chem 2004, 52(16):5032-5039.
• [40]McKenna DJ, Jones K, Hughes K: Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications. Altern Ther Health Med 2001, 7(5):70-86.
• [41]Tamborini A, Taurelle R: Value of standardized Ginkgo biloba extract (EGb 761) in the management of congestive symptoms of premenstrual syndrome. Rev Fr Gynecol Obstet 1993, 88(4):47-57.
• [42]Clark H, Wells G, Huët C, McAlister F, Salmi R, Fergusson D, Laupacis A: Assessing the quality of randomized trials: reliability of the jadad scale. Control Clin Trials 1999, 20(5):448-452.